Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of bacterial endocarditis.

B E Giessel1, C J Koenig, R L Blake

  • 1University of Missouri-Columbia School of Medicine, USA.

American Family Physician
|April 6, 2000
PubMed
Summary

Antibiotic selection for bacterial endocarditis depends on the pathogen, valve type, and patient factors. Treatment guidelines, such as those from the American Heart Association, help determine effective antimicrobial strategies for various infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and Characterization of X-Ray Multilayer Analyzers for the 50-1000 eV Region.

Journal of X-ray science and technology·2011
Same author

Spironolactone for congestive heart failure.

The Journal of family practice·2002
Same author

Clinical inquiries. What medications are safe and effective for heartburn during pregnancy?

The Journal of family practice·2001
Same author

Accuracy of hematuria in diagnosing kidney stones.

The Journal of family practice·2000
Same author

Management of giant cell arteritis and polymyalgia rheumatica.

American family physician·2000
Same author

Antihistamines for atopic dermatitis.

The Journal of family practice·2000

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Pharmacology

Background:

  • Bacterial endocarditis commonly involves viridans streptococci, enterococci, and staphylococci.
  • Treatment decisions are guided by pathogen identification, antibiotic susceptibility, valve status (native or prosthetic), and patient allergies.

Purpose of the Study:

  • To outline current antibiotic therapy recommendations for bacterial endocarditis.
  • To provide guidance based on American Heart Association guidelines.

Main Methods:

  • Review of established treatment protocols for bacterial endocarditis.
  • Categorization of therapies based on causative organisms (streptococci, enterococci, staphylococci) and valve type.

Main Results:

  • Penicillin or ceftriaxone for streptococcal infections.
  • Penicillin/ampicillin plus gentamicin for susceptible enterococci; vancomycin for penicillin-resistant strains.
  • Nafcillin, oxacillin, or cefazolin for methicillin-susceptible staphylococci on native valves; triple therapy (rifampin, gentamicin, plus a beta-lactam or vancomycin) for prosthetic valve staphylococcal infections.

Conclusions:

  • Tailored antibiotic regimens are crucial for effective bacterial endocarditis treatment.
  • Emerging vancomycin resistance in enterococci necessitates careful monitoring and alternative strategies.
  • Vancomycin serves as a penicillin alternative for hypersensitive patients.

Related Experiment Videos